GW Pharma Reports Success with THC and CBD Combo in Brain Cancer Phase 2 Clinical Trial

GW Pharm
GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma

GW intends to advance oncology research and development efforts

LONDON, Feb. 07, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused

... read more at: